131 related articles for article (PubMed ID: 18237462)
21. Pharmacokinetics of tolbutamide and its metabolite 4-hydroxy tolbutamide in poloxamer 407-induced hyperlipidemic rats.
Choi MR; Kwon MH; Cho YY; Choi HD; Kim YC; Kang HE
Biopharm Drug Dispos; 2014 Jul; 35(5):264-74. PubMed ID: 24590592
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin.
Kim YC; Oh EY; Kim SH; Lee MG
Biopharm Drug Dispos; 2006 Mar; 27(2):85-92. PubMed ID: 16312011
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
Ramakrishna R; Bhateria M; Singh R; Bhatta RS
J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic interaction between DA-8159, a new erectogenic, and metformin in rats: competitive inhibition of metabolism via hepatic CYP3A1/2.
Choi YH; Chung SJ; Lee MG
Br J Pharmacol; 2008 Apr; 153(7):1568-78. PubMed ID: 18204480
[TBL] [Abstract][Full Text] [Related]
25. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous torasemide in rats.
Lee DY; Lee SJ; Lee MG
Int J Pharm; 2005 Jul; 298(1):38-46. PubMed ID: 15890479
[TBL] [Abstract][Full Text] [Related]
26. Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1/2.
Choi YH; Lee YS; Kim TK; Lee BY; Lee MG
J Pharm Pharmacol; 2009 Oct; 61(10):1325-32. PubMed ID: 19814864
[TBL] [Abstract][Full Text] [Related]
27. Effects of sinapic acid on hepatic cytochrome P450 3A2, 2C11, and intestinal P-glycoprotein on the pharmacokinetics of oral carbamazepine in rats: Potential food/herb-drug interaction.
Raish M; Ahmad A; Ansari MA; Alkharfy KM; Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Khan A; Ali N
Epilepsy Res; 2019 Jul; 153():14-18. PubMed ID: 30927680
[TBL] [Abstract][Full Text] [Related]
28. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA-8159, a new erectogenic, in rats.
Kim YC; Shim HJ; Lee JH; Kim SH; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2005 Sep; 26(6):233-41. PubMed ID: 15926192
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic changes in drugs during protein-calorie malnutrition: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes.
Lee JH; Suh OK; Lee MG
Arch Pharm Res; 2004 Jul; 27(7):693-712. PubMed ID: 15356995
[TBL] [Abstract][Full Text] [Related]
30. In vivo effects of scutellarin on the activities of CYP1A2, CYP2C11, CYP2D1, and CYP3A1/2 by cocktail probe drugs in rats.
Lin Z; Guo S; Yang C; Yu Y; Xu L; Liu G
Pharmazie; 2014 Jul; 69(7):537-41. PubMed ID: 25073400
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporine and bromocriptine-induced suppressions of CYP3A1/2 and CYP2C11 are not mediated by prolactin.
Lu SK; Callahan SM; Jin R; Brunner LJ
Eur J Pharmacol; 2004 Oct; 501(1-3):215-24. PubMed ID: 15464081
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of intravenous and oral DA-8159, a new erectogenic, in rats with protein-calorie malnutrition.
Shim HJ; Kim YC; Lee JH; Ahn BO; Kwon JW; Kim WB; Lee I; Lee MG
J Pharm Pharmacol; 2004 Dec; 56(12):1543-50. PubMed ID: 15563761
[TBL] [Abstract][Full Text] [Related]
33. Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11.
Chung HJ; Kang HE; Bae EJ; Lee I; Kim SG; Lee MG
J Pharm Sci; 2008 Nov; 97(11):5024-36. PubMed ID: 18314883
[TBL] [Abstract][Full Text] [Related]
34. Effects of vitexin on the pharmacokinetics and mRNA expression of CYP isozymes in rats.
Wang XS; Hu XC; Chen GL; Yuan X; Yang RN; Liang S; Ren J; Sun JC; Kong GQ; Gao SG; Feng XS
Phytother Res; 2015 Mar; 29(3):366-72. PubMed ID: 25447838
[TBL] [Abstract][Full Text] [Related]
35. Effects of diabetes mellitus induced by alloxan on the pharmacokinetics of metformin in rats: restoration of pharmacokinetic parameters to the control state by insulin treatment.
Lee MG; Choi YH; Lee I
J Pharm Pharm Sci; 2008; 11(1):88-103. PubMed ID: 18445367
[TBL] [Abstract][Full Text] [Related]
36. Changes in metformin pharmacokinetics after intravenous and oral administration to rats with short-term and long-term diabetes induced by streptozotocin.
Choi YH; Lee DC; Lee I; Lee MG
J Pharm Sci; 2008 Dec; 97(12):5363-75. PubMed ID: 18393297
[TBL] [Abstract][Full Text] [Related]
37. Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase.
Chang TK; Chan MM; Holsmer SL; Bandiera SM; Bellward GD
Biochem Pharmacol; 1996 Feb; 51(3):357-68. PubMed ID: 8573203
[TBL] [Abstract][Full Text] [Related]
38. Changes of midazolam pharmacokinetics in Wistar rats treated with lipopolysaccharide: relationship between total CYP and CYP3A2.
Kato R; Yamashita S; Moriguchi J; Nakagawa M; Tsukura Y; Uchida K; Amano F; Hirotani Y; Ijiri Y; Tanaka K
Innate Immun; 2008 Oct; 14(5):291-7. PubMed ID: 18809653
[TBL] [Abstract][Full Text] [Related]
39. Interaction of drugs and Chinese herbs: pharmacokinetic changes of tolbutamide and diazepam caused by extract of Angelica dahurica.
Ishihara K; Kushida H; Yuzurihara M; Wakui Y; Yanagisawa T; Kamei H; Ohmori S; Kitada M
J Pharm Pharmacol; 2000 Aug; 52(8):1023-9. PubMed ID: 11007075
[TBL] [Abstract][Full Text] [Related]
40. Effect of sodium alterations on hepatic cytochrome P450 3A2 and 2C11 and renal function in rats.
Liu J; Callahan SM; Brunner LJ
Drug Dev Ind Pharm; 2003 Aug; 29(7):767-75. PubMed ID: 12906334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
